Considering overexpression of EGFL6 and activation of PI3K/Akt pathway in fibroblastic meningioma, we speculated that EGFL6 played a role in the pathogenesis of benign meningioma via activating PI3K/Akt pathway. This evidence concerns the gene EGFL6 and benign meningioma.